The abnormal upregulation of CXCR1 and CXCR2 correlates with adverse clinical characteristics and laboratory indicators in AL patients, predisposing them to extramedullary infiltration, difficult-to-treat recurrence, and other poor prognostic outcomes, highlighting their importance in disease monitoring and prognosis evaluation. This evidence concerns the gene CXCR1 and axial length measurement.